Oncology Times

Skip Navigation LinksHome > January 10, 2010 - Volume 32 - Issue 1 > Update: Nancy Brinker Names Komen CEO
Text sizing:
Oncology Times:
doi: 10.1097/01.COT.0000366135.67210.d8

Update: Nancy Brinker Names Komen CEO

Free Access

Right after our December 25th issue went to press with the news that Susan G. Komen for the Cure founder Nancy G. Brinker would now be taking a more active role after CEO Hala Moddelmog left the organization suddenly in November, it was announced that Ms. Brinker will now be Chief Executive Officer and that Mike Williams would be interim President, a separation of roles that had previously been held by Ms. Moddelmog. Komen officials had previously told OT that there were no plans to find a replacement CEO. Mr. Williams had served as Komen's interim Chief Financial Officer before that position was filled early in 2009.

No Caption Available...
No Caption Available...
Image Tools

As of now there is no additional information regarding the search for a permanent president, or about what the specific roles would be for each executive position.

Nancy Brinker...
Nancy Brinker...
Image Tools

Eric T. Rosenthal

© 2010 Lippincott Williams & Wilkins, Inc.

More on ONCOLOGY-TIMES.com...
Home  Clinical Resource Center
Current Issue       Search OT
Archives Get OT Enews
Blogs Email us!



Article Tools



Article Level Metrics

Pamela Tarapchak

ISSN: 0276-2234

Online ISSN: 1548-4688

Connect with us...